Jeffrey Stouthamer

Business Development | Innovation | Strategy | Risk Management |

Utrecht, Utrecht, Netherlands

About

Experience

  • RheoLight by Ink Invent (Nieuwegein, Utrecht, Netherlands · Hybrid)
    • Chief Strategy Officer (CSO)
      Aug 2024 - Present · 1 yr 11 mos

    • Director Business Development
      Jan 2023 - Present · 3 yrs 6 mos

      Ink Invent BV is an Effect Pigment Manufacturer based in Nieuwegein, The Netherlands, and developed RheoLight™: the first member of a new class of Effect Pigments - Crystal Glass Pigments. Developed as a universal platform technology, RheoLight™ is easy to incorporate into existing coating and binder systems. The RheoLight™ crystal glass microsphere dispersions and mono-concentrates are compatible with existing industrial production and application processes - giving the ability to designers and formulators in every industry to create unique new dynamic colors for aesthetic appeal and increased visibility.

    • Director Regulatory Affairs
      Jun 2022 - Sep 2024 · 2 yrs 4 mos

  • Owner SQRS B.V. at SQRS
    Jan 2016 - Present · 10 yrs 6 mos

    Quality Assurance and Regulatory Affairs consultancy in the Medical Device and Pharmaceutical Industry

  • Director QA/RA at AQPHA Medical BV
    Feb 2016 - Oct 2020 · 4 yrs 9 mos

    Founding Management Team member, Management Representative (ISO13485), PRRC- Person Responsible for Regulatory Compliance (MDR 2017/745).

  • Director QA/RA, Director R&D at AQLANE Medical BV
    Feb 2018 - Jan 2019 · 1 yr

    Management Team member, Management Representative (ISO13485). • Leading the organization through the final stage of the Technical Documentation Review (TDR) to obtain CE mark for the Class III Medical device (Urolon) for the treatment of Stress Urinary Incontinence (SUI) - Obtained CE mark June 2018 • Maintaining a suitable and effective QMS compliant to ISO13485 • Upgrade QMS ISO13485:2003 certification to 2016 version - Obtained re-certification August 2018 • Initiation of the transition plan from MDD (93/42/EEC) to MDR (2017/745) to ensure compliance

  • AQTIS Medical™, a Sinclair company (Utrecht Area, Netherlands)
    • Director Quality Assurance
      Sep 2013 - Jan 2016 · 2 yrs 5 mos

      Management Team member, Management Representative (ISO13485), Member of Corporate Company Safety Group (Sinclair IS Pharma), Internal Auditor for Corporate group QMS

    • Quality Control Manager
      Oct 2010 - Jan 2014 · 3 yrs 4 mos

      AQTIS Medical is a Dutch based, medical technology company developing and commercializing products for minimal invasive therapies. Founded in November 2006, AQTIS Medical's core competence lies in the modification, functionalization and commercialisation of bioresorbable (co)polymers